Bibliography
- COLEMAN RA, SMITH, WL, NARUMIYA S: International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev. (1994) 46:205–229.
- ABRAMOVITZ M, ADAM M, BOIE Y et al.: The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs. Biochim. Biophys. Acta. (2000) 1483(2):285–293.
- UNGRIN MD, CARRIERE MC, DENTS D et al: Key structural features of prostaglandin E2 and prostanoid analogs involved in binding and activation of the human EPi prostanoid receptor. MM. Pharmacol (2001) 59:1446–1456.
- •Invaluable definition of SAR at this receptor.
- BREYER RM: Prostaglandin EPi receptor subtype selectivity takes shape. MM.Phannacol (2001) 59:1357–1359.
- •Brief but useful review.
- HALLINAN EA, HAGEN TJ, TSYMBALOV S et al.: 2,4-Disubstituted oxazoles and thiazoles as latent pharmacophores for diacylhydrazine of SC-51089, a potent PGE2 antagonist. Bioorg. Med. Chem. (2001) 9(1):1–6.
- SARKAR S, HOBSON AR, HUGHES A et al.: The prostaglandin E2 receptor-1 (EP-1) mediates acid-induced visceral pain hypersensitivity in humans. (2003) Gastroenterology 124(1):18–25.
- KAWAMORI T, UCHIYA N, KITAMURA T et al.: Evaluation of a selective prostaglandin E receptor EP1 antagonist for potential properties in colon carcinogenesis. Anticancer Res. (2001) 21(6A):3865–3869.